You have   6 free profiles   left this month    Start Your Free Trial ➤
Hey, we noticed you're a RelSci Pro subscriber! Would you like to view the page there? View on RelSci Pro ➤

Mark W. Leuchtenberger

President, Chief Executive Officer & Director at IRX Therapeutics, Inc.
Relationship Science aggregates deep and verified information on over 6 million influential decision makers and the 2 million organizations with which they are associated. From this data, we create a "business social graph" that highlights who knows whom. Here are Mark W. Leuchtenberger's strongest connections.

People Most Closely Connected to Mark W. Leuchtenberger

Click the names below to expand relationship details.
John W. Hadden II
Founder at IRX Therapeutics, Inc.
Peter Feinstein
Co-Founder at Massachusetts Biotechnology Council
Garen Bohlin
Partner at Arthur Andersen
Mark J. Fitzpatrick
Director, President, Chief Executive Officer, Chief Financial Officer, Treasurer & Secretary at Chiasma, Inc.
Daniel Katzman
Founder at NeuroHealing Pharmaceuticals, Inc.
Robert K. Coughlin
President & Chief Executive Officer at Massachusetts Biotechnology Council
Jeffrey F Eisenberg
Chief Executive Officer at Xenetic Biosciences, Inc.
David H. Deming
Managing Partner at TAG Healthcare Advisors
George P. Denny III
Former Partner at Bain & Co., Inc.
Charles R. Cherington
Co-Founder at Intervale Capital
John D. Halpern
Co-Founder at Halpern, Denny & Co.
Lawrence M. Wolf
Former Partner at Arthur Andersen LLP
Ferid Murad
University Professor, Biochemistry & Molecular Biology at The George Washington University
Roman Knyazev
Senior Investment Manager at SynBio
Timothy D. Hunt
Senior Vice President of Corporate Affairs at Editas Medicine, Inc.
Dmitry Genkin
Director & Partner at Fds Pharma Associates Ltd.
Roy Lobb
Venture Partner at Advent Venture Partners LLP
Firdaus Jal Dastoor
Former Company Secretary at Poonawalla Group of Cos.
There are 2,946 more people accessible only with RelSci Professional.